New gene shot could regrow knee cartilage and ease arthritis pain
NCT ID NCT05454566
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This early-phase study tests a single injection of ICM-203, a gene therapy that delivers a gene to promote cartilage growth and reduce inflammation in the knee. About 18 adults with mild to moderate knee osteoarthritis will receive escalating doses to check safety and whether it improves pain and function. The goal is to see if this approach can control the disease and ease symptoms.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OSTEOARTHRITIS, KNEE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a common painkiller sabotage your knee treatment?
- Can a Mind-Body program ease knee pain and lift mood?
- Which knee implant feels more natural? a trial puts two designs to the test
- Could a quick insulin shot stop Steroid-Induced blood sugar spikes?
- Which Nerve-Blocking technique offers better knee pain relief?
- Knee replacement pain: can a simple injection match a nerve block?